up 269-6 has been researched along with Injury, Myocardial Reperfusion in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jugdutt, BI; Menon, V; O'Brien, DW; Xu, Y | 1 |
| Jugdutt, BI; Kumar, D; Menon, V; Moudgil, R; Musat-Marcu, S; Xu, Y | 1 |
2 other study(ies) available for up 269-6 and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Efficacy of pretreatment with the angiotensin II type 1 receptor blocker UP269-6 and losartan in the dog: effect on hemodynamics and ischemia-reperfusion.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Dogs; Dose-Response Relationship, Drug; Female; Hemodynamics; Losartan; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Pyrimidines; Random Allocation; Receptors, Angiotensin; Tetrazoles | 2000 |
Postischemic apoptosis and functional recovery after angiotensin II type 1 receptor blockade in isolated working rat hearts.
Topics: Angiotensin Receptor Antagonists; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspases; In Vitro Techniques; Losartan; Male; Myocardial Reperfusion Injury; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Tetrazoles; Tumor Suppressor Protein p53; Ventricular Function, Left | 2001 |